Beijing Centergate (000931)

Overview

Beijing Centergate Technologies (Holding) Co., Ltd. is a versatile company entrenched in several high-demand sectors, including pharmaceuticals, construction, real estate development, and property management. With a global footprint, the company leverages its integrated business model to cater to diverse market needs. Founded in 1999 and headquartered in Beijing, China, Beijing Centergate has expanded its reach both domestically and internationally, illustrating its commitment to growth and innovation across its various lines of business.

Products and Services

Beijing Centergate Technologies (Holding) Co., Ltd. offers a wide variety of products and services across multiple industries, reflected in their diverse portfolio:

• Huasu West-Ground Iodine, Fesser Phenylcycline Hydrochloride, Bosu Fuma Acid Bisolol, Yuanji Beni Flat Hydrochloric Acid, Naloxone Hydrochloride, Five Plus Biochemical, and Aramol Quramado Tablets and Capsules: This range of chemical and biochemical products addresses various health concerns, showcasing the company's capacity to produce pharmaceuticals that cater to diverse medical needs.
• Mucous Membrane Repair and Oral Health Care Products: Including toothpaste, mouthwash, spray, dental equipment, and other oral care products. These offerings are designed for ulcers, burns, mechanical damage, and postoperative repair, highlighting the company's commitment to comprehensive health and wellness solutions.
• Food Enzymes and Probiotics: The company provides a selection of fruit enzymes, imported fungella enzymes, functional probiotics, and soda, among other edible grade raw materials. These products are tailored for consumers seeking health-boosting dietary supplements and ingredients.
• Investments in High-tech Sectors: Beijing Centergate actively invests in cutting-edge sectors, including software technology, communications and electronic engineering, biomedicine, and life sciences, demonstrating its forward-looking approach and commitment to innovation.